Our activities in the Greater China region
Evonik Industries has been producing specialty chemical products in the Greater China region (Mainland China, Hong Kong and Taiwan) since the late 1970’s with wide-ranging trading relations already in place prior to this in the region. Evonik regards Greater China as one of the driving forces of the global economy and we consequently endeavour to grow our business in the region. The company now employs about 3,000 employees in Greater China, and has in total of 10 production sites. The regional sales reached over €1.3 billion in 2015.
The multi-user-site-China (MUSC)
To facilitate the establishment of new business activities in the Greater China region, Evonik embarked on the construction of a multi-user site in Shanghai Chemical Industry Park (SCIP) in 2004. The site now houses the production plants of methyl methacrylate, isophorone & isophorone diamine, specialty organics, silicone surfactants (under construction) and other Evonik advanced products. All business segments of Evonik in China can benefit from the leading technology, equipment and joint infrastructure facilities on site. Till 2015, there are over 650 people working at the MUSC site with an area of over 375,000m². The accumulated investment reached over €600 million.
People are our most important assets
Evonik regards people as the most important assets for our sustainable growth. Wherever possible, we aim to fill key positions with highly qualified local managers and offer them attractive career opportunities in the Group. Exploring opportunities. Growing together. is our commitment as the top employer in China - Evonik has been awarded for nine times one of Page 3 of 3 “China’s Top Employers” by the international publishing company Top Employers Institute since 2007.
Innovation is a key growth driver
Evonik Industries—one of the world’s most innovative companies. That is the vision that guides our research and development. Innovative strength and efficient R&D drives profitable and sustainable growth for Evonik. We are continuously working on these strengths by networking and internationalizing our research, through forward-thinking and openness to external ideas, and by continuing to invest in creative minds. We have increased R&D expenditures by an average of 6% per year since 2010. In 2015, they totaled €434 million. Page 2 of 3 For years, Evonik has been stepping up R&D in the Asian growth markets, aiming to help strengthen the competitiveness of our Asian customers through research and applications technology geared specifically to regional megatrends and local needs. Alongside our applications technology laboratories at several sites, the R&D center in ShanghaiXinzhuang plays a key role in Evonik’s global R&D strategy. Its rapid expansion since 2003 reflects Evonik’s strong focus on “innovation in China for China”.
We are convinced that sustainability - in social, environmental, and economic terms, and corporate responsibility are vital for the future viability of Evonik. We therefore accept responsibility worldwide - for our business, our employees, the environment and society. Our CR strategy takes up the megatrends identified in our corporate strategy and supplements them with ecological and societal challenges. We aims to grow sustainability and find solutions to pressing future challenges for and with our customers by empowering them to offer product solutions and services that demonstrate a good balance of economic, ecological and social factors. Our Environment, Safety, Health and Quality (ESHQ) Values also define protection of people and the environment as central elements of our activities. We therefore have guiding principles for safety and a uniform, Group-wide safety culture that sets high standards. Over 95% of our global production has been validated externally as conforming to ISO 14001, the internationally recognized environmental management standard. Evonik is committed to the global Responsible Care® initiative worldwide.